Clinical trial
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
NCT07193069 is registered in ClinicalTrials.gov with Centre Hospitalier de Saint-Denis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
- Lead sponsor
- Centre Hospitalier de Saint-Denis
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 11, 2025
- Completion date
- April 11, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dapagliflozin, diabetic ketoacidosis, drug overdose, intensive care units, lactic acidosis, metformin